Oral betaine administration was shown to decrease fasting glucose concentrations, improve insulin-resistance and thereby alleviate NAFLD in high-fat diet-fed insulin resistance NAFLD mouse models (Kathirvel et al., 2010
Restless legs syndrome in Wilsons disease: frequency, characteristics, and mimics
This guide breaks down the pharmacology, the mechanistic contrast, the head-to-head trial evidence (including the 2025 SURMOUNT-5 results), what enthusiast and research communities online are saying, and the practical realities of sourcing both compounds in Canada
This material is not approved for human or animal use and is not offered as a therapeutic, diagnostic, or clinical product
Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans